We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+10.98%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.7B
AUM Growth
-$4.56M
(-0.01%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-8.5%
Top 10 Holdings %
Top 10 Hldgs %
19.9%
Holding
801
New
88
Increased
169
Reduced
396
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$165M |
| 2 |
Costco
COST
|
+$134M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$126M |
| 4 |
Johnson Controls International
JCI
|
+$121M |
| 5 |
3M
MMM
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$136M |
| 3 |
Marathon Petroleum
MPC
|
+$123M |
| 4 |
CenterPoint Energy
CNP
|
+$123M |
| 5 |
Under Armour
UAA
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.42% |
| 2 | Healthcare | 16.85% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Cooper Companies
COO
$14.1B
| $18.4M | 0.05% |
229,196
-11,600
| -5% | -$875K |
|
402
Lennar Class A
LEN
$19.8B
| $18.4M | 0.05% |
339,771
-16,012
| -5% | -$913K |
|
403
Ironwood Pharmaceuticals
IRWD
$696M
| $18.3M | 0.04% |
1,375,000
+700,000
| +104% | +$7.72M |
|
404
Keysight
KEYS
$54.5B
| $18.2M | 0.04% |
177,625
-10,400
| -6% | -$1.06M |
|
|
ADN
405
DELISTED
Advent Technologies
ADN
| $18.2M | 0.04% |
60,000
| – | – |
|
|
ALUS.U
406
DELISTED
Alussa Energy Acquisition Corp
ALUS.U
| $18.1M | 0.04% |
+1,800,000
| New | +$18.1M |
|
407
Genuine Parts
GPC
$17.1B
| $17.9M | 0.04% |
168,200
+101,837
| +153% | +$10.5M |
|
408
Baker Hughes
BKR
$60B
| $17.7M | 0.04% |
692,102
-86,000
| -11% | -$1.96M |
|
409
Acuity Brands
AYI
$9.83B
| $17.7M | 0.04% |
+127,956
| New | +$16.5M |
|
|
ETFC
410
DELISTED
E*Trade Financial Corporation
ETFC
| $17.6M | 0.04% |
388,341
+98,000
| +34% | +$4.19M |
|
411
Fortinet
FTNT
$119B
| $17.5M | 0.04% |
820,590
-39,500
| -5% | -$743K |
|
|
KSU
412
DELISTED
Kansas City Southern
KSU
| $17.3M | 0.04% |
113,000
-5,500
| -5% | -$807K |
|
413
Mid-America Apartment Communities
MAA
$15.4B
| $17.3M | 0.04% |
130,950
-6,300
| -5% | -$843K |
|
414
Expedia Group
EXPE
$35.4B
| $17.2M | 0.04% |
159,300
-7,700
| -5% | -$904K |
|
|
GRTX
415
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $17.1M | 0.04% |
+1,300,000
| New | +$15.9M |
|
|
TIF
416
DELISTED
Tiffany & Co.
TIF
| $16.9M | 0.04% |
+126,173
| New | +$14.9M |
|
417
CarMax
KMX
$8.13B
| $16.7M | 0.04% |
+190,800
| New | +$17.9M |
|
418
Wabtec
WAB
$49.1B
| $16.5M | 0.04% |
212,493
+20,147
| +10% | +$1.49M |
|
419
Akamai
AKAM
$16.7B
| $16.5M | 0.04% |
190,600
-8,900
| -4% | -$778K |
|
420
Abeona Therapeutics
ABEO
$366M
| $16.4M | 0.04% |
200,000
+80,000
| +67% | +$5.64M |
|
421
Tradeweb Markets
TW
$21.4B
| $16.3M | 0.04% |
351,894
+163,092
| +86% | +$7.03M |
|
|
GRMN
422
Garmin
GRMN
$56.7B
| $16.3M | 0.04% |
167,079
+21,335
| +15% | +$1.99M |
|
423
Immunovant
IMVT
$7.93B
| $16.2M | 0.04% |
+1,020,000
| New | +$11.4M |
|
424
Quest Diagnostics
DGX
$25.7B
| $16.1M | 0.04% |
151,200
-7,500
| -5% | -$782K |
|
|
HOLX
425
DELISTED
Hologic
HOLX
| $16.1M | 0.04% |
307,876
+165,200
| +116% | +$8.22M |
|
Similar funds
Adage Capital Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Adage Capital Partners held 801 positions worth $40.7B, down 0.01% from $40.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Adage Capital Partners withdrew a net $3.46B in Q4 2019, closing 90 positions and reducing 396 holdings. Its most notable exit was Celgene Corp, an estimated $1.48B position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $142M.
- Adage Capital Partners's largest Q4 2019 buy was Bristol-Myers Squibb: 2,207,539 shares worth $142M.
- Adage Capital Partners added most to RTX Corp in Q4 2019, an estimated $165M increase.
- Adage Capital Partners's biggest Q4 2019 reduction was Apple, cutting an estimated $136M.
- Adage Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.48B.
- Adage Capital Partners's ten largest holdings make up 20% of its $40.7B portfolio in Q4 2019.
- Adage Capital Partners opened 88 new positions and closed 90 in Q4 2019.
- Adage Capital Partners's portfolio value fell 0.01% quarter-over-quarter to $40.7B.
Based on Adage Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.